Rydex Biotechnology Fund Class A (RYBOX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
49.98
-1.02 (-2.00%)
May 9, 2025, 9:45 AM EDT
-19.58% (1Y)
| Fund Assets | 117.21M |
| Expense Ratio | 1.65% |
| Min. Investment | $2,500 |
| Turnover | n/a |
| Dividend (ttm) | 9.42 |
| Dividend Yield | 17.96% |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | Dec 12, 2024 |
| Previous Close | 51.00 |
| YTD Return | -7.13% |
| 1-Year Return | -4.95% |
| 5-Year Return | 1.41% |
| 52-Week Low | n/a |
| 52-Week High | n/a |
| Beta (5Y) | n/a |
| Holdings | 80 |
| Inception Date | Sep 1, 2004 |
About RYBOX
The Fund's investment strategy focuses on Health/Biotech with 1.73% total expense ratio. The minimum amount to invest in Rydex Series Funds: Biotechnology Fund; A-Class Shares is $2,500 on a standard taxable account. Rydex Series Funds: Biotechnology Fund; A-Class Shares seeks capital appreciation by investing in companies that are involved in the biotechnology industry.
Category Health
Performance Rating Below Average
Risk Rating Above Average
Stock Exchange NASDAQ
Ticker Symbol RYBOX
Share Class Class A
Index S&P 500 TR
Performance
RYBOX had a total return of -4.95% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.06%.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
| Symbol | Provider | Name | Expense Ratio |
|---|---|---|---|
| FIKCX | Fidelity | Fidelity Advisor Health Care Fund - Class Z | 0.59% |
| FSPHX | Fidelity | Fidelity Select Health Care Portfolio | 0.63% |
| FIJYX | Fidelity | Fidelity Advisor Biotechnology Fund - Class Z | 0.61% |
| FACDX | Fidelity | Fidelity Advisor Health Care Fund - Class A | 0.98% |
| FSHCX | Fidelity | Fidelity Select Health Care Services Portfolio | 0.67% |
Top 10 Holdings
41.01% of assets| Name | Symbol | Weight |
|---|---|---|
| AbbVie Inc. | ABBV | 9.13% |
| Amgen Inc. | AMGN | 5.92% |
| Gilead Sciences, Inc. | GILD | 5.74% |
| Vertex Pharmaceuticals Incorporated | VRTX | 4.43% |
| Regeneron Pharmaceuticals, Inc. | REGN | 3.66% |
| Corteva, Inc. | CTVA | 2.92% |
| AstraZeneca PLC | AZN | 2.49% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 2.41% |
| First American Government Obligations Fund | FGXXX | 2.24% |
| Royalty Pharma plc | RPRX | 2.07% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 12, 2024 | $9.42277 | Dec 12, 2024 |
| Dec 20, 2022 | $0.89943 | Dec 20, 2022 |
| Dec 8, 2021 | $15.77303 | Dec 8, 2021 |
| Dec 9, 2020 | $6.95038 | Dec 9, 2020 |
| Dec 10, 2019 | $3.60206 | Dec 10, 2019 |
| Dec 11, 2018 | $9.88842 | Dec 11, 2018 |